Skip to main content
ER Wait Times

Sarah Cannon Cancer Network of Excellence

Sarah Cannon at SMC

Sarah Cannon Network of Excellence & Swedish Medical Center

Fighting Cancer Together

Swedish Medical Center is now home to the Sarah Cannon Cancer Network of Excellence, and we are:

  • Bringing greater access to cutting-edge therapies for patients
  • Implementing physician-led and patient-centric integrated care programs
  • Easing the burden of the cancer journey for all patients through new nurse navigation programs, assisting the patient through his or her experience
  • Building centers of excellence with our physicians and staff

Sarah Cannon is the cancer service line of Swedish Medical Center's parent company, Hospital Corporation of America (HCA), and is recognized for advancing science and transforming care in communities across the United States and United Kingdom.

By joining the Sarah Cannon Cancer Network of Excellence, Swedish Medical Center is bringing even more cutting-edge cancer care services closer to our patients and their families. This collaboration means you’ll have even greater access to one of the world’s leading teams of cancer specialists, breakthrough researchers, and compassionate caregivers right here. So, shoulder to shoulder, we can fight this battle together.

Have Cancer Questions?

>A cancer diagnosis can be confusing, but you don’t have to navigate it alone. Sarah Cannon, the global cancer institute of HCA, in partnership with Swedish Medical Center at HealthONE is pleased to offer 24/7 access to askSARAH- a helpline answered by nurses designed to help answer your cancer questions. Call askSARAH to speak to a registered nurse at (303) 253-3225.

Sarah Cannon Research Institute is the research arm of Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials. Sarah Cannon has led approximately 200 first-in-man clinical trials since its inception in 1993, and has been a clinical trial leader in approximately 80 percent of approved cancer therapies in the last 10 years. To learn more about Sarah Cannon’s active clinical trials, including many in the greater Denver area, contact 1-877-691-7274.